14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
It is a reasonable extrapolation – and we are nothing at Cooley if not wildly reasonable – that mo...
Read More >
On October 10, 2019, Gov. Gavin Newsom signed into law Assembly Bill 51. While styled as a bill pert...
Read More >
Cross-border M&A remains a high priority—though trade wars and national security rules change the g...
Read More >
Seyfarth Synopsis: Recently, when affirming summary judgment to the employer in a disability discrim...
Read More >
Seyfarth Summary: Like the singers in “California Dreamin,” many out-of-state employers—on a wint...
Read More >
New Jersey has enacted a new law prohibiting employers from seeking or relying on job applicants’ s...
Read More >